It’s believed that while CBD helps activate and regulate the body’s endocannabinoid system, it also helps regulate the neural pathways that are responsible for withdrawal symptoms and drug cravings. In early rat trials, those treated with CBD were less likely to exhibit anxiety-related withdrawal symptoms and drug-seeking behaviors after being exposed to cocaine. (40)
There has been a fair amount of confusion surrounding the legality of CBD oil. But while the vast majority of cannabinoids are controlled substances under the Misuse of Drugs Act, rest assured that CBD oil is legal across the UK for medicinal purposes, provided it has been derived from an industrial hemp strain that is EU-approved. These strains contain very little to no THC (the psychoactive cannabinoid).
At the most basic level, CBD interacts with the body’s endocannabinoid system and is widely believed to directly impact the brain’s CB1 receptors – the same receptors that certain anxiety medications interact with – lessening the effects of anxiety and related conditions. This allows sufferers to live more normal lives, free from the constraints of anxiety. That’s just the tip of the iceberg… the positive effects of CBD for anxiety are incredible!
The list of cannabinoids currently comprises 113 entries, with more and more additions each year. Of these 113, by far the best documented are tetrahydrocannabinol and cannabidiol (in this order), with the two also being the most abundant constituents of the cannabis plant. In a typical chemical isolation process, cannabidiol makes up a little under half of the entire extract.
The disturbing problem regarding the current status of cannabidiol is expressed in the same source. Institutional endeavors by the Food and Drug Administration to classify it as a drug are in its infancy. Nevertheless, this should mean that CBD could no longer be marketed as a dietary supplement, as that class of products is subject to ridiculously lax regulation. However, there are countless companies (some no larger than a newsstand, while others are listed on the stock exchange) that sell supplements containing cannabidiol (as oil, capsules, sprays, etc.) unencumbered by either state or federal authorities.
More recent experiments, involving the administration of a part CBD part THC solution, have yielded results that contradict the first supposition. At present, on the evidence that cannabidiol reduces some of the psychoactive effects of tetrahydrocannabinol (acting as a de facto antidepressant), scientists argue that cannabidiol has a holistic but indirect influence on all cannabinoid receptors in the endocannabinoid system. The main consequence of this impact seems to be an increase in the production of endocannabinoids. This is now the prevailing idea that accounts for the mountains of empirical evidence of how the benefits of cannabidiol are expressed at the cellular level.
A study highlighting this was performed approximately one decade ago. The study found a link between IBS sufferers and clinical endocannabinoid deficiency, which relates back to the fact that the system directly impacts intestinal motility and function. When CBD was used to activate and regulate the endocannabinoid system, sufferers of IBS saw significant symptom improvement. (42)
While CBD and marijuana have been used for centuries for many remedies, the role CBD can play in lessening the severity and number of seizures in those diagnosed with epilepsy came into the spotlight in the early 2000’s. That’s when the Figi family began looking for a way to treat their daughter Charlotte’s seizures. At the time, she was suffering upwards of 300 seizures per week. (8)
As mentioned in previous conditions, these treatments are often associated with devastating side effects, ranging from mild mood changes, sleeping problems and/or appetite changes to depression, dependance and more. In many cases, as patients become acclimated to specific doses, they are increased, leading to a higher potential for negative effects.